Literature DB >> 16143897

Hypertransaminasemia: the end of a thread.

Akira Matsui.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16143897     DOI： 10.1007/s00535-005-1675-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  10 in total

1.  Serum glutamic pyruvic transaminase in cardiac with hepatic disease.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1956-04

2.  Serum glutamic oxalacetic aminopherase (transaminase) in hepatitis.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  J Am Med Assoc       Date:  1956-03-31

3.  Congenital disorder of glycosylation type Ia revealed by hypertransaminasemia and failure to thrive in a young boy with normal neurodevelopment.

Authors:  Cristina Pancho; Angels Garcia-Cazorla; Vincente Varea; Rafael Artuch; Immaculada Ferrer; Maria A Vilaseca; Paz Briones; Juame Campistol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-02       Impact factor: 2.839

Review 4.  [Hereditary hemochromatosis].

Authors:  S Durupt; I Durieu; R Nové-Josserand; L Bencharif; H Rousset; D Vital Durand
Journal:  Rev Med Interne       Date:  2000-11       Impact factor: 0.728

5.  [Chronic idiopathic hypertransaminasemia].

Authors:  L Zancan; T Bettiol; A Rini; R Giacchino; P Gandullia; P Vajro; M Marcellini; S Musumeci; G Di Leo; F Balli; P Bragetti; M Calacoci; C Barbera
Journal:  Minerva Pediatr       Date:  1996-05       Impact factor: 1.312

6.  Hypertransaminasemia in childhood as a marker of genetic liver disorders.

Authors:  Raffaele Iorio; Angela Sepe; Antonietta Giannattasio; Francesco Cirillo; Angela Vegnente
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

7.  Persistent hypertransaminasemia as the presenting finding of childhood muscle disease.

Authors:  J Rutledge; J Andersen; C W Fink; J Cook; A Strickland
Journal:  Clin Pediatr (Phila)       Date:  1985-09       Impact factor: 1.168

8.  Sibling cases of chronic recurrent hepatocerebral disease with hypercitrullinemia.

Authors:  T Tsujii; T Morita; Y Matsuyama; T Matsui; M Tamura; Y Matsuoka
Journal:  Gastroenterol Jpn       Date:  1976

Review 9.  Characterization of liver involvement in defects of cholesterol biosynthesis: long-term follow-up and review.

Authors:  Massimiliano Rossi; Pietro Vajro; Raffaele Iorio; Antonella Battagliese; Nicola Brunetti-Pierri; Gaetano Corso; Maja Di Rocco; Paola Ferrari; Francesco Rivasi; Raffaella Vecchione; Generoso Andria; Giancarlo Parenti
Journal:  Am J Med Genet A       Date:  2005-01-15       Impact factor: 2.802

10.  [Hypertransaminasemia greater than 400 U/l in adults seen at a tertiary hospital. Prospective study of etiology].

Authors:  M Bruguera; J M Barrera; F Corradi; A Mas
Journal:  Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.102
  10 in total
  1 in total

Review 1.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.